P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
David Oliver: Deaths from hospital acquired covid are everyone’s problem
16 June 2021Vaccinating children against SARS-CoV-2: maximise uptake among adults while prioritising the most vulnerable
16 June 2021P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
AbstractObjectiveTo assess the risks and benefits of P2Y12 inhibitor monotherapy compared with dual antiplatelet therapy (DAPT) and whether these associations are modified by patients’…
